Abstract:Background: Few studies have focused on the clinical pathological features and initial treatment of focal segmental glomerulosclerosis (FSGS) in Asian populations. There is a lack of large-sample-size retrospective studies of primary FSGS in Chinese patients. Methods: This retrospective study included 808 patients diagnosed with primary FSGS, between January 2003 until December 2017. This study aimed to explore the prevalence of pathological and clinical features of primary FSGS over the past 15 years, as well as characteristics of each variant under the Columbia classification, a recognized pathological classification. A total of 361 patients were classified by the Columbia classification, of which 277 underwent regular follow-ups (6 months - 60 months). According to follow-up data, the current study summed up the best initial treatment based on proteinuria and Columbia classification. Results: As the years have progressed, the proportion of pFSGS patients, among all renal biopsy patients, has decreased gradually. Detection rates of 2003-2007, 2008-2012, and 2013-2017 were, respectively, 14.7%, 9.7%, and 7.9%. The proportion of pFSGS patients, among primary glomerular disease (PGD), has also decreased, respectively 22.5%, 14.5%, and 11.1%. Over time, the proportion of glomerular segmental sclerosis has gradually decreased, while the proportion of glomerular global sclerosis has gradually increased. In the current study, NOS showed the highest prevalence of (73.6%), followed by perihilar (14.1%), tip (9.2%), and collapsing variants (2.5%). Cellular variants had the lowest prevalence (0.6%). Present results showed that, in Perihilar with moderate proteinuria, simple ACEI/ARB, as an initial treatment, can bring satisfactory remission rates. Regarding NOS and tip, ACEI/ARB combined with steroids can lead to better remission rates. For Tip with severe proteinuria, steroids alone are able to obtain satisfactory remission rates. With NOS, remission rates of steroids + CTX are better than those of steroids alone or steroids + CNIs. Conclusion: Over the past 15 years, FSGS detection rates of renal biopsies and PGD have shown a downward trend. Over time, the proportion of glomerular segmental sclerosis has gradually decreased, while the proportion of glomerular global sclerosis has gradually increased, with aging as an independent factor in this trend. In choosing an initial treatment, the combination of both proteinuria and Columbia classification may bring higher remission rates.

Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review

Case Report and Literature Review: A De Novo Pathogenic Missense Variant in ACTN4 Gene Caused Rapid Progression to End-Stage Renal Disease

Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis

Novel Pathogenic Mutation of P209L in TRPC6 Gene Causes Adult Focal Segmental Glomerulosclerosis

NPHS2 mutation (431C>A) in a nephrotic patient with focal and segmental glomerulonephrosis

The Clinical Course and Long-Term Outcome of Primary Focal Segmental Glomerulosclerosis in Chinese Adults.

Clinical Characteristics and Prognosis of Genetic Focal Segment Glomerulosclerosis

Clinical Pathological Characteristics And Initial Treatment Of Primary Focal Segmental Glomerulosclerosis In Chinese Patients

[Clinical and Pathological Characteristics of Focal Segmental Glomerulosclerosis in Children].

Case Report: The Monogenic Familial Steroid-Resistant Nephrotic Syndrome Caused by a Novel Missense Mutation of NPHS2 Gene A593C in a Chinese Family

Mutation in XPO5 causes adult-onset autosomal dominant familial focal segmental glomerulosclerosis

Recent Advances in the Treatment of Focal Segmental Glomerulosclerosis

Effect of cyclosporine A on focal segmental glomerulosclerosis caused by MYO1E mutation in a Chinese adult patient: A case report

A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 ( RCAN1 ) Gene Confers Enhanced Calcineurin Activity and May Cause FSGS

Increased Risk of Treatment Failure and End-Stage Renal Disease in Familial Focal Segmental Glomerular Sclerosis.

Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.

The Clinical and Genetic Features in Chinese Children With Steroid-Resistant or Early-Onset Nephrotic Syndrome: A Multicenter Cohort Study

Novel TBC1D8B variant causes neonatal nephrotic syndrome combined with acute kidney injury

Novel Variants in CRB2 Targeting the Malfunction of Slit Diaphragm Related to Focal Segmental Glomerulosclerosis

Patients with Primary Focal Segmental Glomerulosclerosis with Detectable Urinary CD80 Are More Similar to Patients with Minimal Change Disease in Clinicopathological Features

Case Report: A Novel Heterozygous Mutation of CD2AP in a Chinese Family With Proteinuria Leads to Focal Segmental Glomerulosclerosis